Fresenius Medical Care US Finance III New $1 Billion Commercial Paper Program Rated'A-3' - S&P Global Ratings’ Credit Research

Fresenius Medical Care US Finance III New $1 Billion Commercial Paper Program Rated'A-3'

Fresenius Medical Care US Finance III New $1 Billion Commercial Paper Program Rated'A-3' - S&P Global Ratings’ Credit Research
Fresenius Medical Care US Finance III New $1 Billion Commercial Paper Program Rated'A-3'
Published Oct 30, 2026
Published Oct 30, 2026
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

FRANKFURT (S&P Global Ratings) Oct. 30, 2026--S&P Global Ratings today assigned its'A-3'issue rating to Fresenius Medical Care US Finance III Inc's (FME US) new $1 billion commercial paper (CP) program, which will be unconditionally guaranteed by Fresenius Medical Care AG (FME, BBB-/Stable/A-3). The borrowings under the CP program will rank pari passu with all FME and FME US'other unsecured and unsubordinated debt. All of our existing ratings on FME, including the'BBB-'long-term issuer credit rating, remain unchanged. For a detailed credit rating rationale and latest forecasts please see our most recent publication''Fresenius Medical Care AG ,"Sept. 14, 2026. ARCHIVE Criteria Corporates General: Sector-Specific Corporate Methodology , April 4, 2024 Criteria

  
Report Type:

Ratings Action

Issuer
Fresenius Medical Care US Finance III Inc.
Sector
Global Issuers
Region
United States
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Fresenius Medical Care US Finance III New $1 Billion Commercial Paper Program Rated'A-3'" Oct 30, 2026. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/Fresenius-Medical-Care-US-Finance-III-New-1-Billion-Commercial-Paper-Program-Rated-A-3-3652685>
  
APA:
S&P Global Ratings’ Credit Research. (). Fresenius Medical Care US Finance III New $1 Billion Commercial Paper Program Rated'A-3' Oct 30, 2026. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/Fresenius-Medical-Care-US-Finance-III-New-1-Billion-Commercial-Paper-Program-Rated-A-3-3652685>
  
US$ 150.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.